Thomson Reuters Q1 Beats, Maintains Outlook; AI Monetization on Track

What happened

Thomson Reuters reported strong Q1 2026 results with total revenues up 10% and organic growth of 8%, ahead of the ~7% checkpoint flagged in our prior analysis. The Big 3 segments delivered 9% organic growth, and the company maintained its full-year 2026 outlook for organic revenue, EBITDA margin, and free cash flow. Management also increased the dividend by 10% to $2.62 and executed $605 million in capital returns, demonstrating confidence in cash generation. While the GenAI-enabled ACV penetration was not disclosed, the revenue momentum supports the thesis that AI attach is converting to paid growth rather than eroding pricing. The results reduce the probability of the bear case and keep the base case of $105 intact, though we await more detail on margins and ACV mix in the full filing.

Implication

The Q1 print validates the investment thesis that Thomson Reuters can sustain ~7.5% organic growth and expand margins despite AI competition. The maintained full-year guidance and increased capital returns suggest management sees no deterioration in pricing power. However, we still need evidence that GenAI-enabled ACV is sequentially rising beyond 28% to confirm the attach-driven model. If the full filing shows margin expansion in line with the ~42% EBITDA margin target, the stock could re-rate toward our base-case $105. Conversely, any signs of discounting or stalled ACV growth would re-introduce bear risks. We maintain our POTENTIAL BUY rating with a bias to add on any pullbacks.

Thesis delta

Q1 exceeded our near-term checkpoint (organic growth ~7% actual 8%), shifting the balance of probabilities toward the base case (55% probability) and away from the bear case. The maintained full-year outlook and strong capital return signal management's confidence, but we need H1 2026 data on GenAI ACV to fully confirm the monetization narrative. Therefore, the thesis becomes slightly more constructive but remains conditional on ACV mix improvement in the coming quarters.